查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1971127

医疗设备软体市场分析及预测（至2035年）：类型、产品类型、服务、技术、组件、应用、部署类型、最终用户、功能、解决方案

Software as a Medical Device Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Deployment, End User, Functionality, Solutions
出版日期: | 出版商: Global Insight Services | 英文 375 Pages | 商品交期: 3-5个工作天内

价格
简介目录

软体即医疗设备(SaMD) 市场预计将从 2024 年的 573 亿美元成长到 2034 年的 3,209 亿美元，复合年增长率约为 18.8%。软体即医疗器材 (SaMD) 市场涵盖旨在独立于硬体执行医疗功能的软体解决方案。这些应用能够诊断、监测和治疗疾病，并提供进阶分析和即时数据洞察。由于法规结构的不断完善、个人化医疗的需求以及人工智慧和机器学习技术的融合，SaMD 解决方案正日益受到关注。在数位医疗日益普及和对以患者为中心的创新医疗解决方案的需求推动下，该市场呈现出成长势头。

在数位医疗技术进步和监管支援的推动下，医疗器材软体（SaMD）市场持续稳定成长。慢性病盛行率的上升以及对远端患者监护需求的增长，使得诊断和监护软体在性能方面处于主导。针对心理健康和慢性病管理的治疗软体也紧随其后，反映出对个人化治疗方案日益增长的需求。行动应用程式凭藉其易用性和便利性，正获得显着的市场认可，而云端平台则因其可扩展性和整合能力而备受青睐。人工智慧（AI）驱动的SaMD解决方案正成为提高诊断准确性和预测分析能力的关键趋势。与现有医疗保健系统的互通性至关重要，它有助于实现无缝资料交换并改善患者预后。为了因应人们对资料隐私和保护的担忧，网路安全措施方面的投资正在不断增加。监管合规性和对临床检验的重视仍然是重中之重，以确保SaMD解决方案的安全性和有效性。

市场区隔
类型 诊断、治疗和监测软体
产品 行动应用、穿戴式装置软体、云端解决方案、桌面应用、Web解决方案、内建软体
服务 咨询服务、实施服务、训练及支援服务、维护服务
科技 人工智慧、机器学习、区块链、物联网 (IoT)、巨量资料分析、云端运算、扩增实境、虚拟现实
成分 软体平台、软体工具、软体库
应用 慢性病管理、远端患者监护、医学影像、数位疗法
实施表格 本机部署、云端部署、混合式部署
最终用户 医疗服务提供者、病患、临床研究机构、製药公司
功能 资料管理、病患管理、临床决策支援、远端医疗
解决方案 互通性解决方案、安全解决方案、合规性解决方案、资料分析解决方案

市场概况：

软体即医疗设备(SaMD) 市场的市场动态特征是市场占有率波动、定价策略竞争激烈以及新产品层出不穷。为了满足日益增长的数位医疗技术需求，市场正朝着更复杂、更人性化的解决方案转型。各公司正致力于将人工智慧和机器学习技术融入创新，以增强产品功能。在北美和欧洲等医疗基础设施发达的地区，SaMD 的普及率显着，而新兴市场正逐步迎头赶上。这种情况催生了一个竞争激烈的市场环境，各公司都在寻求透过独特的价值主张和策略联盟来实现差异化。随着现有企业和新参与企业争夺市场主导地位，SaMD 市场的竞争日益激烈。基准研究表明，主要企业正在大力投资研发，以保持其竞争优势。监管机构，特别是美国食品药物管理局(FDA) 和欧盟委员会的影响力，对塑造市场动态至关重要。遵守严格的监管标准至关重要，各公司将产品品质和安全性放在首位。监管环境不断演变，重点在于确保病患安全和资料安全，这给市场参与企业带来了挑战和机会，他们需要应对复杂的法规结构，并将创新解决方案推向市场。

主要趋势和驱动因素：

在技​​术进步和监管支援的推动下，软体定义医疗设备(SaMD) 市场正经历变革性成长。关键趋势包括将人工智慧 (AI) 和机器学习技术应用于诊断，以提高诊断准确性和个人化治疗。这些技术能够实现即时数据分析，从而改善患者预后并提高营运效率。此外，穿戴式装置和行动医疗应用的广泛应用也拓展了 SaMD 解决方案的应用范围。消费者对远端监测和远距远端医疗服务的需求不断增长，也推动了这一趋势。监管机构在製定明确的指导方针和框架方面发挥关键作用，这些方针和框架既促进了创新，也保障了病人安全。向价值医疗模式的转变也是一个重要的驱动因素，因为相关人员正在寻求能够带来卓越疗效且成本效益高的解决方案。此外，慢性病盛行率的不断上升也对创新数位医疗解决方案提出了更高的要求，进一步推动了 SaMD 市场的发展。对于能够开发扩充性、互通性且能与现有医疗系统无缝整合的平台的公司而言，存在着众多机会。

限制与挑战：

医疗器材软体（SaMD）市场面临许多重大限制与挑战。监管的复杂性仍然是一大障碍，企业需要投入大量资源和专业知识才能应对各种全球标准。这种监管负担会延缓产品上市，增加企业成本，并阻碍市场扩张。资料安全和隐私问题也是重大挑战。 SaMD应用通常处理敏感的患者讯息，因此强大的网路安全措施至关重要。资料外洩可能会削弱消费者信任，并导致严重的法律后果，从而阻碍企业采用这项技术。互通性问题也阻碍了市场成长。 SaMD解决方案必须与现有医疗保健系统无缝集成，但技术和标准的差异使这一过程变得复杂。实现相容性需要大量投资和先进的技术能力。此外，科技的快速发展需要持续创新。为了保持竞争力，企业必须在研发方面投入大量资金，从而加剧财务压力。最后，随着新参与企业和老牌企业争夺市场主导，市场竞争日益激烈。这种竞争格局迫使企业进行差异化，这往往会导致激进的定价策略。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 诊断软体
    • 治疗软体
    • 监控软体
  • 市场规模及预测：依产品划分
    • 行动应用
    • 穿戴式装置软体
    • 基于云端的解决方案
    • 桌面应用程式
    • 网路为基础的解决方案
    • 嵌入式软体
  • 市场规模及预测：依服务划分
    • 咨询服务
    • 实施服务
    • 培训和支援服务
    • 维护服务
  • 市场规模及预测：依技术划分
    • 人工智慧
    • 机器学习
    • 区块链
    • 物联网 (IoT)
    • 巨量资料分析
    • 云端运算
    • 扩增实境（AR）
    • 虚拟实境
  • 市场规模及预测：依组件划分
    • 透过软体平台
    • 软体工具
    • 软体库
  • 市场规模及预测：依应用领域划分
    • 慢性病管理
    • 远端患者监护
    • 医学影像诊断
    • 数位疗法
  • 市场规模及预测：依发展状况
    • 本地部署
    • 基于云端的
    • 杂交种
  • 市场规模及预测：依最终用户划分
    • 医疗保健提供者
    • 病人
    • 临床研究所
    • 製药公司
  • 市场规模及预测：依功能划分
    • 资料管理
    • 病患管理
    • 临床决策支持
    • 远端医疗
  • 市场规模及预测：按解决方案划分
    • 互通性解决方案
    • 安全解决方案
    • 合规解决方案
    • 数据分析解决方案

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • Zebra Medical Vision
  • Viz.ai
  • Qure.ai
  • Aidoc
  • Aidence
  • HeartFlow
  • Arterys
  • iSchemaView
  • CureMetrix
  • Imbio
  • Ultromics
  • Oxipit
  • Therapixel
  • Lunit
  • Quantib

第九章：关于我们

简介目录
Product Code: GIS34281

Software as a Medical Device Market is anticipated to expand from $57.3 billion in 2024 to $320.9 billion by 2034, growing at a CAGR of approximately 18.8%. The Software as a Medical Device (SaMD) Market encompasses software solutions designed to perform medical functions independently of hardware. These applications diagnose, monitor, and treat diseases, offering advanced analytics and real-time data insights. With regulatory frameworks evolving, SaMD solutions are gaining traction, driven by the need for personalized healthcare and the integration of AI and machine learning technologies. The market is poised for growth, influenced by increased digital health adoption and the demand for innovative, patient-centric care solutions.

The Software as a Medical Device (SaMD) Market is experiencing robust expansion, fueled by advancements in digital health technologies and regulatory support. Diagnostic and monitoring software leads in performance, driven by the rising prevalence of chronic diseases and the demand for remote patient monitoring. Therapeutic software, addressing mental health and chronic condition management, follows closely, reflecting the increasing need for personalized treatment solutions. Mobile applications, offering ease of use and accessibility, are gaining significant traction, while cloud-based platforms are preferred for their scalability and integration capabilities. Artificial Intelligence (AI)-powered SaMD solutions are emerging as a key trend, enhancing diagnostic accuracy and predictive analytics. The interoperability of SaMD with existing healthcare systems is crucial, promoting seamless data exchange and improved patient outcomes. Investment in cybersecurity measures is rising, addressing concerns over data privacy and protection. The emphasis on regulatory compliance and clinical validation remains paramount, ensuring the safety and efficacy of SaMD solutions.

Market Segmentation
TypeDiagnostic Software, Therapeutic Software, Monitoring Software
ProductMobile Applications, Wearable Device Software, Cloud-Based Solutions, Desktop Applications, Web-Based Solutions, Embedded Software
ServicesConsulting Services, Implementation Services, Training and Support Services, Maintenance Services
TechnologyArtificial Intelligence, Machine Learning, Blockchain, Internet of Things (IoT), Big Data Analytics, Cloud Computing, Augmented Reality, Virtual Reality
ComponentSoftware Platforms, Software Tools, Software Libraries
ApplicationChronic Disease Management, Remote Patient Monitoring, Medical Imaging and Diagnostics, Digital Therapeutics
DeploymentOn-Premise, Cloud-Based, Hybrid
End UserHealthcare Providers, Patients, Clinical Research Organizations, Pharmaceutical Companies
FunctionalityData Management, Patient Management, Clinical Decision Support, Telemedicine
SolutionsInteroperability Solutions, Security Solutions, Compliance Solutions, Data Analytics Solutions

Market Snapshot:

Software as a Medical Device (SaMD) market dynamics are characterized by evolving market shares, competitive pricing strategies, and a surge in new product launches. The market is witnessing a shift towards more sophisticated, user-friendly solutions that cater to the growing demand for digital health technologies. Companies are focusing on innovation, integrating AI and machine learning to enhance functionalities. Regions with advanced healthcare infrastructure, such as North America and Europe, are seeing significant adoption rates, while emerging markets are gradually catching up. This landscape is fostering a competitive environment where companies strive to differentiate through unique offerings and strategic partnerships. Competition in the SaMD market is intensifying, with established players and new entrants vying for market dominance. Benchmarking reveals that leading firms are investing heavily in R&D to maintain a competitive edge. Regulatory influences, particularly from the FDA and European Commission, are pivotal in shaping market dynamics. Compliance with stringent regulatory standards is crucial, driving companies to prioritize quality and safety in their offerings. The regulatory landscape is evolving, with a focus on ensuring patient safety and data security. This creates both challenges and opportunities for market participants, as they navigate complex regulatory frameworks to bring innovative solutions to market.

Geographical Overview:

The Software as a Medical Device (SaMD) market is flourishing globally, with distinct regional dynamics. North America leads, driven by technological innovation and robust regulatory frameworks supporting SaMD adoption. The presence of leading tech companies and significant healthcare investments further propel the market. Europe follows, with strong regulatory support and a focus on patient safety and data privacy. The region's commitment to healthcare innovation fosters a conducive environment for SaMD growth. In Asia Pacific, the market is expanding rapidly, fueled by increasing healthcare digitization and supportive government initiatives. Countries like China and India are emerging as key growth pockets, driven by large patient populations and rising healthcare demands. Latin America and the Middle East & Africa are nascent markets with growing potential. In these regions, increasing healthcare investments and digital transformation efforts are opening new opportunities for SaMD adoption.

Key Trends and Drivers:

The Software as a Medical Device (SaMD) market is experiencing transformative growth driven by technological advancements and regulatory support. Key trends include the integration of artificial intelligence and machine learning to enhance diagnostic accuracy and treatment personalization. These technologies enable real-time data analysis, improving patient outcomes and operational efficiency. Furthermore, the proliferation of wearable devices and mobile health applications is expanding the reach of SaMD solutions. This trend is supported by increasing consumer demand for remote monitoring and telehealth services. Regulatory bodies are also playing a pivotal role by establishing clear guidelines and frameworks that facilitate innovation while ensuring patient safety. The shift towards value-based healthcare is another significant driver, as stakeholders seek cost-effective solutions that deliver superior outcomes. Additionally, the growing prevalence of chronic diseases necessitates innovative digital health solutions, further propelling the SaMD market. Opportunities abound for companies that can develop scalable, interoperable platforms that seamlessly integrate with existing healthcare systems.

Restraints and Challenges:

The Software as a Medical Device (SaMD) market encounters several significant restraints and challenges. Regulatory complexities remain a formidable obstacle, as navigating diverse global standards demands substantial resources and expertise. This regulatory burden can delay product launches and inflate costs for companies, hindering market expansion. Data security and privacy concerns pose another critical challenge. SaMD applications often handle sensitive patient information, necessitating robust cybersecurity measures. Breaches can erode consumer trust and result in severe legal repercussions, deterring potential adopters. Interoperability issues also impede market growth. SaMD solutions must seamlessly integrate with existing healthcare systems, yet disparate technologies and standards complicate this process. Achieving compatibility requires considerable investment and technical prowess. Furthermore, the rapid pace of technological advancement creates a continuous need for innovation. Companies must invest heavily in research and development to stay competitive, straining financial resources. Finally, market competition intensifies as new entrants and established players vie for dominance. This competitive landscape pressures companies to differentiate their offerings, often leading to aggressive pricing strategies.

Key Players:

Zebra Medical Vision, Viz.ai, Qure.ai, Aidoc, Aidence, HeartFlow, Arterys, iSchemaView, CureMetrix, Imbio, Ultromics, Oxipit, Therapixel, Lunit, Quantib

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Deployment
  • 2.8 Key Market Highlights by End User
  • 2.9 Key Market Highlights by Functionality
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Diagnostic Software
    • 4.1.2 Therapeutic Software
    • 4.1.3 Monitoring Software
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Mobile Applications
    • 4.2.2 Wearable Device Software
    • 4.2.3 Cloud-Based Solutions
    • 4.2.4 Desktop Applications
    • 4.2.5 Web-Based Solutions
    • 4.2.6 Embedded Software
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Consulting Services
    • 4.3.2 Implementation Services
    • 4.3.3 Training and Support Services
    • 4.3.4 Maintenance Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Artificial Intelligence
    • 4.4.2 Machine Learning
    • 4.4.3 Blockchain
    • 4.4.4 Internet of Things (IoT)
    • 4.4.5 Big Data Analytics
    • 4.4.6 Cloud Computing
    • 4.4.7 Augmented Reality
    • 4.4.8 Virtual Reality
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Software Platforms
    • 4.5.2 Software Tools
    • 4.5.3 Software Libraries
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Chronic Disease Management
    • 4.6.2 Remote Patient Monitoring
    • 4.6.3 Medical Imaging and Diagnostics
    • 4.6.4 Digital Therapeutics
  • 4.7 Market Size & Forecast by Deployment (2020-2035)
    • 4.7.1 On-Premise
    • 4.7.2 Cloud-Based
    • 4.7.3 Hybrid
  • 4.8 Market Size & Forecast by End User (2020-2035)
    • 4.8.1 Healthcare Providers
    • 4.8.2 Patients
    • 4.8.3 Clinical Research Organizations
    • 4.8.4 Pharmaceutical Companies
  • 4.9 Market Size & Forecast by Functionality (2020-2035)
    • 4.9.1 Data Management
    • 4.9.2 Patient Management
    • 4.9.3 Clinical Decision Support
    • 4.9.4 Telemedicine
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Interoperability Solutions
    • 4.10.2 Security Solutions
    • 4.10.3 Compliance Solutions
    • 4.10.4 Data Analytics Solutions

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Deployment
      • 5.2.1.8 End User
      • 5.2.1.9 Functionality
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Deployment
      • 5.2.2.8 End User
      • 5.2.2.9 Functionality
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Deployment
      • 5.2.3.8 End User
      • 5.2.3.9 Functionality
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Deployment
      • 5.3.1.8 End User
      • 5.3.1.9 Functionality
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Deployment
      • 5.3.2.8 End User
      • 5.3.2.9 Functionality
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Deployment
      • 5.3.3.8 End User
      • 5.3.3.9 Functionality
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Deployment
      • 5.4.1.8 End User
      • 5.4.1.9 Functionality
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Deployment
      • 5.4.2.8 End User
      • 5.4.2.9 Functionality
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Deployment
      • 5.4.3.8 End User
      • 5.4.3.9 Functionality
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Deployment
      • 5.4.4.8 End User
      • 5.4.4.9 Functionality
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Deployment
      • 5.4.5.8 End User
      • 5.4.5.9 Functionality
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Deployment
      • 5.4.6.8 End User
      • 5.4.6.9 Functionality
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Deployment
      • 5.4.7.8 End User
      • 5.4.7.9 Functionality
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Deployment
      • 5.5.1.8 End User
      • 5.5.1.9 Functionality
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Deployment
      • 5.5.2.8 End User
      • 5.5.2.9 Functionality
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Deployment
      • 5.5.3.8 End User
      • 5.5.3.9 Functionality
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Deployment
      • 5.5.4.8 End User
      • 5.5.4.9 Functionality
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Deployment
      • 5.5.5.8 End User
      • 5.5.5.9 Functionality
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Deployment
      • 5.5.6.8 End User
      • 5.5.6.9 Functionality
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Deployment
      • 5.6.1.8 End User
      • 5.6.1.9 Functionality
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Deployment
      • 5.6.2.8 End User
      • 5.6.2.9 Functionality
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Deployment
      • 5.6.3.8 End User
      • 5.6.3.9 Functionality
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Deployment
      • 5.6.4.8 End User
      • 5.6.4.9 Functionality
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Deployment
      • 5.6.5.8 End User
      • 5.6.5.9 Functionality
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Zebra Medical Vision
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Viz.ai
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Qure.ai
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Aidoc
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Aidence
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 HeartFlow
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Arterys
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 iSchemaView
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 CureMetrix
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Imbio
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Ultromics
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Oxipit
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Therapixel
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Lunit
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Quantib
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us